Viewing Study NCT00160992


Ignite Creation Date: 2025-12-24 @ 3:45 PM
Ignite Modification Date: 2026-01-07 @ 1:39 PM
Study NCT ID: NCT00160992
Status: SUSPENDED
Last Update Posted: 2005-09-12
First Post: 2005-09-08
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Adoptive Cell Transfer Combined With Peptide Vaccination in Transiently Immunosuppressed Melanoma Patients
Sponsor: University of Lausanne Hospitals
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: CePO-ITA-01
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None UNKNOWN View
None OTHER View
None NETWORK View